techsciresearch logo

Press Release

United Kingdom Generic Drugs Market Led To Growth By Obesity Control Medicines

The United Kingdom Generic Drugs Market, 2023-2027F may grow with expanding pharmaceutical industry in the country.

According to TechSci report on, “United Kingdom Generic Drugs Market - By Region, Competition Forecast & Opportunities, 2027”United Kingdom generic drugs market may flourish with an impressive CAGR during the forecast period of 2023-2027, on the backbone of growing demands for effective and cheaper drugs for treatment. Rising instances of chronic diseases that require prolonged medication further drives the growth of the United Kingdom generic drugs market in the upcoming five years. Low cost of generic drugs, and as a perfect alternative for the branded drugs the demands for the generic drugs surges rapidly. Higher prevalence of robotic process automation and its utilization to facilitate the pharmaceutical demands and patient care further facilitates the growth of the United Kingdom generic drugs market in the next five years. Moreover, use of artificial intelligence to make the drug routines automated along with the rule based process is also aiding the market growth. The market players utilize the robotic process automation and artificial intelligence to regulate and standardize the product quality. Growing prevalence of these procedures and product standardization would support the authenticity of the generic drug thereby substantiating the growth of the United Kingdom generic drugs market in the forecast years through 2027.

Furthermore, COVID-19 also had severe impact over the generic drug market in the United Kingdom. Although the supply chain disruption posed as restraining factor toward the industrial growth, the demand for the generic drugs for the symptomatic relief from the coronavirus infection aided the growth of the United Kingdom generic drugs market in the forecast period.

Browse over XX market data Figures spread through 70 Pages and an in-depth TOC on "United Kingdom Generic Drugs Market"


The United Kingdom generic drugs market is segmented by type, mode of drug delivery, form, source, distribution channel, application, competitional landscape, and regional distribution. Based on type, the market is differentiated between small molecule generics and biosimilars. Biosimilars are anticipated to hold the largest revenue shares of the market and dominate the market segment in the upcoming five years on grounds of growing demand for the affordable and equally effective drugs as the branded medicines. Growing demands for the treatment drugs against obesity, diabetes, and high blood pressure also facilitate the growth of the segment along with the growth of the United Kingdom generic drugs market in the next five years.

By mode of drug delivery, the market is further segmented into oral, topical, parenteral, and others. Oral drug delivery may lead the segment in the upcoming five years and hold the largest revenue shares of the market due to easier drug delivery through the oral route of administration. Based on form, the market is fragmented into tablet, capsule, injection, and others. By source, the market is differentiated into in house and contract manufacturing organizations. Based on distribution channel, the market is bifurcated into hospital pharmacies, retail pharmacies, and online pharmacies. By application, the market is also segmented into cardiovascular diseases, diabetes, neurology, oncology, anti-inflammatory diseases, and others. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among London, East Anglia, Southwest, Southeast, Scotland, East Midlands, and Yorkshire & Humberside.

A partial list of major market players of the United Kingdom generic drugs market includes :

·         GlaxoSmithKline Plc.

·         Abbott Laboratories Limited

·         Eli Lilly and Company Limited

·         Teva UK Limited

·         Mylan UK Healthcare Limited

·         Pfizer Limited

·         Novartis UK Limited

·         Sun Pharmaceuticals UK Limited

Download Sample Report @

Customers can also request for 10% free customization on this report.


“Growing demand for the generic drugs and affordable medicine for various categorical diseases drive the growth of the market. Pharmaceutical industry is rapidly expanding in the country growing on the backbone of higher investments and increasing expenses over pharmaceutical products by the consumers. Although National Healthcare Services (NHS) provides majority of the healthcare products and services for the consumers, private sector of the healthcare has been recently expanding rapidly and aiding the overall industrial growth in the recent years. Also, due to the lifestyle of the population, there has been a surge in the number of populations looking to overcome the consequences of lifestyle diseases like diabetes, obesity, and infectious diseases like anti-inflammatory diseases, bacterial infections etc. and thus aiding the growth of the United Kingdom generic drugs market in the future five years. New market players may focus on the research and development along with product development with advanced technologies to support their brand establishment in the market players,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

United Kingdom Generic Drugs Market By Type (Small Molecule Generics v/s Biosimilars), By Mode of Drug Delivery (Oral, Topical, Parenteral, Others), By Form (Tablet, Capsule, Injection, Others), By Source (In House v/s Contract Manufacturing Organizations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, Others), By Region, Competition Forecast & Opportunities, 2027 has evaluated the future growth potential of United Kingdom generic drugs market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in United Kingdom generic drugs market.


Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]


Relevant News